111 MUTATIONAL PROFILE AND KARYOTYPIC ABNORMALITIES OF...

111 MUTATIONAL PROFILE AND KARYOTYPIC ABNORMALITIES OF CLINICAL TRIAL PATIENTS WITH HIGHER-RISK MDS FOLLOWING FAILURE OF HYPOMETHYLATING AGENTS (HMAS): IMPACT ON RESPONSE TO RIGOSERTIB THERAPY

Mufti, G.J., Best, S., Lea, N., Hellstrom-Lindberg, E., Silverman, L.R., Garcia-Manero, G., Azarnia, N., Petrone, M.E., Snyder, B.R., Gohring, G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
39
Language:
english
Journal:
Leukemia Research
DOI:
10.1016/S0145-2126(15)30112-0
Date:
April, 2015
File:
PDF, 99 KB
english, 2015
Conversion to is in progress
Conversion to is failed